Aural Analytics, Inc. Partners with Signant Health to Integrate Its A2E SDK for Current and Future Clinical Trials

PHILADELPHIA & SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Aural Analytics, Inc., an industry leading speech neuroscience and speech analytics technology company, announced today it has partnered with Signant Health (Signant) to integrate its A2E™ mobile application SDK and Web API across Signant Health’s Rater Station™ and TrialMax® training, data quality monitoring and eCOA solutions. A2E is designed to make clinical-grade speech collection and cloud-based analytics ubiquitous across the lifespan and continuum of care.

The partnership begins in service of a global, late phase study in Major Depressive Disorder (MDD), with several more studies planned for development. The initial integration enables 14 languages and in-clinic and remote voice collection. Ultimately the A2E system will power a full suite of speech analytics for the sponsoring pharmaceutical company.

“We are excited to be partnering with Aural Analytics to integrate ubiquitous and seamless speech collection and analytics within our compliant eCOA platforms,” said

Read More
Read More